Recombinant multi-species TTLL4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TTLL4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Predicted to enable tubulin binding activity and tubulin-glutamic acid ligase activity. Predicted to be involved in microtubule cytoskeleton organization and protein polyglutamylation. Predicted to act upstream of or within regulation of blastocyst development. Predicted to be located in cytosol. Predicted to be active in ciliary basal body. [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: 4632407P03Rik,Protein monoglutamylase TTLL4,TTLL4,Ttll4,Tubulin monoglutamylase TTLL4,Tubulin--tyrosine ligase-like protein 4,mKIAA0173
Go
to TTLL4 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP13849-Ag-1/ GM-Tg-hg-IP13849-Ag-2 | Human TTLL4 protein | Human |
| GM-Tg-rg-IP13849-Ag-1/ GM-Tg-rg-IP13849-Ag-2 | Rat TTLL4 protein | Rat |
| GM-Tg-mg-IP13849-Ag-1/ GM-Tg-mg-IP13849-Ag-2 | Mouse TTLL4 protein | Mouse |
| GM-Tg-cynog-IP13849-Ag-1/ GM-Tg-cynog-IP13849-Ag-2 | Cynomolgus/Rhesus macaque TTLL4 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP13849-Ag-1/ GM-Tg-felg-IP13849-Ag-2 | Feline TTLL4 protein | Feline |
| GM-Tg-cang-IP13849-Ag-1/ GM-Tg-cang-IP13849-Ag-2 | Canine TTLL4 protein | Canine |
| GM-Tg-bovg-IP13849-Ag-1/ GM-Tg-bovg-IP13849-Ag-2 | Bovine TTLL4 protein | Bovine |
| GM-Tg-equg-IP13849-Ag-1/ GM-Tg-equg-IP13849-Ag-2 | Equine TTLL4 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP13849-Ag-1/ GM-Tg-hg-IP13849-Ag-2;
GM-Tg-rg-IP13849-Ag-1/ GM-Tg-rg-IP13849-Ag-2;
GM-Tg-mg-IP13849-Ag-1/ GM-Tg-mg-IP13849-Ag-2; GM-Tg-cynog-IP13849-Ag-1/ GM-Tg-cynog-IP13849-Ag-2; GM-Tg-felg-IP13849-Ag-1/ GM-Tg-felg-IP13849-Ag-2; GM-Tg-cang-IP13849-Ag-1/ GM-Tg-cang-IP13849-Ag-2; GM-Tg-bovg-IP13849-Ag-1/ GM-Tg-bovg-IP13849-Ag-2; GM-Tg-equg-IP13849-Ag-1/ GM-Tg-equg-IP13849-Ag-2 |
| Products Name | TTLL4 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | TTLL4 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TTLL4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.